Amgen v Sanofi: The enablement of Sisyphean tasks?
On March 27, the oral arguments for Amgen v. Sanofi were presented before the Supreme Court of the United States. The outcomes: concerning, particularly for industries like the pharmaceutical sector where functional claims are so crucial. The case, which began in 2014, involves Amgen, Inc., et al as plaintiffs, Sanofi, et al as defendants, and […]
English 
Spanish